15:50 · 19 October 2023

BREAKING: EU approves Pfizer's prposed acqusition of Seagen!

Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs. 

Source: xStation5 

9 June 2026, 07:09

OpenAI joins the IPO train, as US markets get more dominant

8 June 2026, 19:06

Apple shares fall amid WWDC conference 📉 No AI breakthrough?

8 June 2026, 15:30

The World Cup on the Market: Is There an Opportunity for Profit?

8 June 2026, 14:57

Intel gains 10% after talks with Google and Nvidia

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.